rxc004,Nivolumab,Denosumab
redx,bms,amgen
['rxc004 ', 'redxpharma']
we were delighted to be joined at by the chief investigator for our rxc004 porcupine clinical trial, professor scott kopetz, the university of texas md anderson cancer center, houston, tx. please click here to view the poster: #oncologyresearch 
Redx Pharma is a biotech company focused on the discovery and development of novel targeted medicines for the treatment of cancer and fibrotic disease.